Volume 71, Issue 7, Pages (April 2007)

Slides:



Advertisements
Similar presentations
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Advertisements

Home care assistance and the utilization of peritoneal dialysis
Volume 81, Issue 5, Pages (March 2012)
Beta blockers in the management of chronic kidney disease
Microalbuminuria, peripheral artery disease, and cognitive function
Volume 83, Issue 3, Pages (March 2013)
Volume 65, Issue 5, Pages (May 2004)
High prevalence of chronic kidney disease in Thailand
Volume 72, Issue 5, Pages (September 2007)
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
John P. Middleton, Patrick H. Pun  Kidney International 
Inflammation and wasting in chronic kidney disease: Partners in crime
Volume 64, Issue 2, Pages (August 2003)
Volume 71, Issue 8, Pages (April 2007)
Volume 70, Pages S21-S25 (December 2006)
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Metabolic syndrome and chronic kidney disease in Okinawa, Japan
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Anemia as a risk factor for chronic kidney disease
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
The epidemiology of chronic kidney disease
H. Wong, K. Mylrea, J. Feber, A. Drukker, G. Filler 
Edmund G. Lowrie  Kidney International 
Volume 75, Issue 1, Pages (January 2009)
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Volume 81, Issue 5, Pages (March 2012)
Fructose intake as a risk factor for kidney stone disease
Volume 73, Issue 12, Pages (June 2008)
Baseline Characteristics of Study Subjects
Anne L. M. Vlek, MD, Yolanda van der Graaf, MD, PhD, Maayke A
The third World Kidney Day: Looking back and thinking forward
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Methods for guideline development
Cardiovascular disease in pediatric chronic dialysis patients
Volume 76, Issue 1, Pages (July 2009)
The global challenge of chronic kidney disease
Volume 73, Issue 7, Pages (April 2008)
Volume 69, Issue 8, Pages (April 2006)
Volume 71, Issue 4, Pages (February 2007)
Volume 73, Issue 8, Pages (April 2008)
Volume 80, Issue 3, Pages (August 2011)
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell  Kara K. Wools-Kaloustian, Samir K. Gupta  Kidney.
Volume 68, Issue 1, Pages (July 2005)
Cardio-Kidney-Damage: a unifying concept
Organ transplantation goes to the movies
Volume 76, Issue 6, Pages (September 2009)
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
Is it the low-protein diet or simply the salt restriction?
Volume 75, Issue 1, Pages (January 2009)
Urinalysis in Western culture: A brief history
Volume 70, Issue 3, Pages (August 2006)
ANCA comes of age—but with caveats
Volume 70, Issue 5, Pages (September 2006)
Volume 75, Issue 7, Pages (April 2009)
Volume 72, Issue 11, Pages (December 2007)
Volume 69, Issue 8, Pages (April 2006)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Metabolic Syndrome and CKD in a General Japanese Population: The Hisayama Study  Toshiharu Ninomiya, MD, PhD, Yutaka Kiyohara, MD, PhD, Michiaki Kubo,
Friends, social networks, and progressive chronic kidney disease
O.M. Gutiérrez, T. Isakova, D.L. Andress, A. Levin, M. Wolf 
The prevalence of hematologic and metabolic abnormalities during chronic kidney disease stages in different ethnic groups  S.J. Barbour, L. Er, O. Djurdjev,
Prediction in idiopathic membranous nephropathy
Sugar-sweetened beverages and chronic disease
Presentation transcript:

Volume 71, Issue 7, Pages 693-700 (April 2007) The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort  C. Kitiyakara, S. Yamwong, S. Cheepudomwit, S. Domrongkitchaiporn, N. Unkurapinun, V. Pakpeankitvatana, P. Sritara  Kidney International  Volume 71, Issue 7, Pages 693-700 (April 2007) DOI: 10.1038/sj.ki.5002128 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Distribution of metabolic syndrome components. The proportion with metabolic syndrome and the number of metabolic syndrome components at entry among (a) all subjects (n=3195) and (b) New CKD subgroup (n=2067). The number of components shown according to ATP III criteria (solid line, solid circles) or modified criteria (dash line, open triangle). Filled columns denote frequency of metabolic syndrome by different definitions. NCEPATP III, metabolic syndrome by NCEP ATP III criteria; NCEPMod, NCEP modified criteria; IDF, IDF criteria. Kidney International 2007 71, 693-700DOI: (10.1038/sj.ki.5002128) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Chronic kidney disease frequency and metabolic syndrome. (a) The prevalence of CKD at entry in all subjects (n=3195) and (b) the incidence of new CKD after 12 years in the new CKD subgroup (n=2067) according to the presence (+, dark columns) or absence (−, light columns) of metabolic syndrome. CKD, chronic kidney disease; NCEPATP III, metabolic syndrome by NCEP ATP III criteria; NCEPMod, metabolic syndrome by NCEP modified criteria; IDF, metabolic syndrome by IDF criteria. Kidney International 2007 71, 693-700DOI: (10.1038/sj.ki.5002128) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Risks of chronic kidney disease. The ORs adjusted for age, sex, and smoking status of (a) CKD at baseline and (b) New CKD after 12 years by the number of metabolic syndrome components present at entry. Numbers of components are defined by either NCEP ATP III (solid line, solid circles) or NCEP Modified criteria (Dash line, open triangle). Kidney International 2007 71, 693-700DOI: (10.1038/sj.ki.5002128) Copyright © 2007 International Society of Nephrology Terms and Conditions